Table 1.
Baseline characteristics of the participants with T1D and controls without diabetes
| Variables | Type 1 diabetes (n=47) | Controls without diabetes (n=47) |
|---|---|---|
| Age (years) | 43.4±8.7 | 44.7±6.9 |
| Duration of diabetes (years) | 28.7±7.5 | NA |
| HbA1c (%) | 7.7±1.0 | 5.4±0.3 |
| Insulin dose (units/kg/day) | 0.6±0.2 | NA |
| BMI ( kg/m2) | 26.1±4.0 | 25.7±4.1 |
| Waist circumference (cm) | 87.1±12.6 | 85.8±12.8 |
| Total fat mass (kg) | 21.8±8.2 | 22.6±7.9 |
| Lean body mass (kg) | 54.8±12.1 | 51.3±13.1 |
| GIR (mg/kg FFM/min) | 5.7±3.7 | 13.2±5.9 |
| SBP (mmHg) | 113.5±10.4 | 113.0±11.8 |
| DBP (mmHg) | 76.1±7.5 | 76.1±7.9 |
| Total Cholesterol (mg/dl) | 158.1±31.5 | 189.1±30.2 |
| HDL-C (mg/dl) | ||
| LDL-C (mg/dl) | 84.4±28.5 | 110.0±28.1 |
| Triglyceride (mg/dl) | ||
| Total hip BMD (g/cm2) | 0.99±0.14 | 0.97±0.15 |
| Lumbar spine BMD L1–L4 (g/cm2) |
1.04±0.15 | 1.02±0.14 |
| TBS | 1.42±0.12 | 1.44±0.08 |
[Statistics are mean ± SD unless specified. T1D; type 1 diabetes, HbA1c; glycated hemoglobin A1c, BMI; body mass index, GIR; glucose infusion rate, FFM; fat free mass, DBP, diastolic blood pressure, SBP; systolic blood pressure, HDL; high density lipoprotein cholesterol, LDL; low density lipoprotein cholesterol, BMD; bone mineral density]